文章基本信息

标题：NEWER DRUGS FOR VISCERAL LEISHMANIASIS: A REVIEW
本地全文：下载
作者：Krishna Pandey ; Dharmendra Singh ; Sanjiva Bimal 等
期刊名称：American Journal of Infectious Diseases
印刷版ISSN：1553-6203
出版年度：2014
卷号：10
期号：2
页码：68-70
DOI：10.3844/ajidsp.2014.68.70
语种：English
出版社：Science Publications
摘要：Visceral Leishmaniasis (VL) is one of the most neglected tropical diseases worldwide. The diagnosis and treatment of this disease is quite complex. Sodium Antimony Gluconate (SAG) which used to be a very effective treatment has now developed resistance and is potentially a cardio-toxic drug. Pentamidine has now been discarded because of adverse effect of diabetes mellitus. Amphotericin-B is an effective drug but can cause nephrotoxicity. Miltefosine is a new oral effective drug which has recently been introduced in the kala-azar elimination program in the Indian subcontinent. Paromomycin is an injectable aminoglycoside which is quite cheap but can cause ototoxicity and nephrotoxicity. Sitamaquine, an oral antimalarial drug is still in phase-II trial stage. Combination Therapy is been tried with good results. Single dose Ambisome (liposomal Amphotericin-B) though costly is a very good alternative.
关键词：Visceral Leishmaniasis; Miltefosine; Paromomycin; Sitamaquine; Combination Therapy; Ambisome